Linnodee has established itself as an expert in the research, development and commercialization of high quality diagnostic tests at its site in Northern Ireland. The company develops new, innovative and rapid diagnostic tests for existing and emerging infectious diseases in animals and humans with particular expertise in Leptospirosis diagnosis. The methodology behind Linnodee’s tests include Enzyme-Linked Immunosorbent Assay (ELISA), Agglutination Tests and Lateral Flow Tests. Linnodee is an accredited organisation, working to ISO Standards 9001 and 13485.
